Q2 2022 Excelsior Newsletter Humira Savings on the Horizon? by Robert Kordella, RPh, MBA, Chief Clinical Officer In 2021, Humira (adalimumab) amassed $21 billion in sales in the U.S. Read More » June 1, 2022 No Comments